Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-22 Purchase | 2024-03-25 4:03 pm | Immuneering Corp | IMRX | Schall Thomas J. Director | 2,900 | $2.5465 | $7,385 | 2,900 (Direct) | View |
2022-08-04 Sale | 2022-08-08 7:41 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 130,000 | $50.24 | $6,531,733 | 2,428,352 (Direct) | View |
2020-12-14 Sale | 2020-12-16 7:51 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 28,772 | $65.02 | $1,870,696 | 2,300,152 (Direct) | View |
2020-06-12 Sale | 2020-06-16 8:20 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 90,753 | $65.08 | $5,905,966 | 2,342,077 (Direct) | View |
2020-05-08 Sale | 2020-05-12 7:50 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 110,674 | $56.22 | $6,221,945 | 2,790,434 (Direct) | View |
2020-05-05 Sale | 2020-05-07 8:11 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 8,851 | $55.01 | $486,851 | 2,505,744 (Direct) | View |
2020-03-04 Sale | 2020-03-05 7:03 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 40,844 | $50.35 | $2,056,691 | 2,689,795 (Direct) | View |
2020-02-19 Sale | 2020-02-21 7:24 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 78,681 | $50.44 | $3,968,809 | 2,857,662 (Direct) | View |
2020-02-04 Sale | 2020-02-06 6:51 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 119,525 | $45.18 | $5,400,701 | 2,634,120 (Direct) | View |
2020-01-16 Sale | 2020-01-17 7:55 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 136,052 | $41.47 | $5,641,441 | 2,452,188 (Direct) | View |
2019-11-26 Sale | 2019-11-27 7:34 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 279,166 | $31.55 | $8,808,112 | 2,228,855 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-12 Option Award | 2024-06-13 4:26 pm | N/A 2034-06-12 | Immuneering Corp | IMRX | Schall Thomas J. Director | 8,588 | $0 | 8,588 (Direct) | View |
2024-03-11 Option Award | 2024-03-12 5:02 pm | N/A 2034-03-11 | Immuneering Corp | IMRX | Schall Thomas J. Director | 35,000 | $0 | 35,000 (Direct) | View |
2022-10-20 Disposition | 2022-10-24 7:01 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 4,847,386 | $0 | 0 (Direct) | View |
2022-08-04 Exercise | 2022-08-08 7:41 pm | N/A 2023-07-23 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 130,000 | $0 | 2,428,352 (Direct) | View |
2022-08-04 Exercise | 2022-08-08 7:41 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 130,000 | $14.28 | 2,428,352 (Direct) | View |
2022-02-22 Option Award | 2022-02-25 8:39 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 345,300 | $0 | 345,300 (Direct) | View |
2022-01-01 Exercise | 2022-01-04 9:42 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 84,234 | $0 | 2,480,586 (Direct) | View |
2022-01-01 Tax Withholding | 2022-01-04 9:42 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 45,698 | $36.41 | 2,480,586 (Direct) | View |
2021-12-01 Exercise | 2021-12-03 7:39 pm | N/A 2022-02-27 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 45,936 | $0 | 2,354,816 (Direct) | View |
2021-12-01 Exercise | 2021-12-03 7:39 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 38,948 | $10.27 | 2,354,816 (Direct) | View |
2021-12-01 Exercise | 2021-12-03 7:39 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 6,988 | $14.31 | 2,354,816 (Direct) | View |
2021-02-25 Option Award | 2021-03-01 9:17 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 133,600 | $0 | 133,600 (Direct) | View |
2021-01-01 Exercise | 2021-01-07 8:40 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 87,899 | $0 | 2,401,348 (Direct) | View |
2021-01-01 Tax Withholding | 2021-01-07 8:40 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 47,576 | $61.92 | 2,401,348 (Direct) | View |
2020-12-14 Exercise | 2020-12-16 7:51 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 28,772 | $0 | 2,300,152 (Direct) | View |
2020-12-14 Exercise | 2020-12-16 7:51 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 28,772 | $14.31 | 2,300,152 (Direct) | View |
2020-06-12 Exercise | 2020-06-16 8:20 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 90,753 | $0 | 2,342,077 (Direct) | View |
2020-06-12 Exercise | 2020-06-16 8:20 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 90,753 | $14.31 | 2,342,077 (Direct) | View |
2020-05-08 Exercise | 2020-05-12 7:50 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 110,674 | $0 | 2,790,434 (Direct) | View |
2020-05-08 Exercise | 2020-05-12 7:50 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 110,674 | $14.31 | 2,790,434 (Direct) | View |
2020-05-05 Exercise | 2020-05-07 8:11 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 8,851 | $0 | 2,505,744 (Direct) | View |
2020-05-05 Exercise | 2020-05-07 8:11 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 8,851 | $14.31 | 2,505,744 (Direct) | View |
2020-03-04 Exercise | 2020-03-05 7:03 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 40,844 | $0 | 2,689,795 (Direct) | View |
2020-03-03 Option Award | 2020-03-05 7:03 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 175,200 | $0 | 2,689,795 (Direct) | View |
2020-03-04 Exercise | 2020-03-05 7:03 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 40,844 | $14.31 | 2,689,795 (Direct) | View |
2020-02-19 Exercise | 2020-02-21 7:24 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 78,681 | $0 | 2,857,662 (Direct) | View |
2020-02-19 Exercise | 2020-02-21 7:24 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 78,681 | $14.31 | 2,857,662 (Direct) | View |
2020-02-04 Exercise | 2020-02-06 6:51 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 119,525 | $0 | 2,634,120 (Direct) | View |
2020-02-04 Exercise | 2020-02-06 6:51 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 119,525 | $14.31 | 2,634,120 (Direct) | View |
2020-01-16 Exercise | 2020-01-17 7:55 pm | N/A 2022-02-27 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 136,052 | $0 | 2,452,188 (Direct) | View |
2020-01-16 Exercise | 2020-01-17 7:55 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 136,052 | $10.27 | 2,452,188 (Direct) | View |
2020-01-01 Tax Withholding | 2020-01-03 5:37 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 46,965 | $39.55 | 2,345,224 (Direct) | View |
2020-01-01 Exercise | 2020-01-03 5:37 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 86,667 | $0 | 2,345,224 (Direct) | View |
2019-11-26 Exercise | 2019-11-27 7:34 pm | 2010-08-11 2020-08-11 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 279,166 | $0 | 2,228,855 (Direct) | View |
2019-11-26 Exercise | 2019-11-27 7:34 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 279,166 | $6.3 | 2,228,855 (Direct) | View |